Arvey Stone

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function

Wayne J. Morgan, Donald R. VanDevanter, David J. Pasta et al. · The Journal of Pediatrics · 2015 · 60 citations

Health Professions, Clinical Sciences, Physiology +16

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Patrick A. Flume, Reta Fischer Biner, D.G. Downey et al. · The Lancet Respiratory Medicine · 2021 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Pressure support noninvasive positive pressure ventilation treatment of acute cardiogenic pulmonary edema

Herbert N. Wigder, Paul Hoffmann, Daniel Mazzolini et al. · The American Journal of Emergency Medicine · 2001 · 25 citations

Medicine, Cardiology, Pulmonology +11

Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis

Youngran Chung, Jerome R. Kraut, Arvey Stone et al. · Pediatric Pulmonology · 1994 · 24 citations

Life Sciences, Immunology, Pediatrics +13

WS7.6 Effect of ivacaftor on lung function in subjects with CF who have the G551D-CFTR mutation and mild lung disease: a comparison of lung clearance index (LCI) vs. spirometry

Jane C. Davies, Helen Sheridan, P.-S. Lee et al. · Journal of Cystic Fibrosis · 2012 · 11 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14